James M. Micali - 25 Apr 2026 Form 4 Insider Report for Urgent.ly Inc. (ULYX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 Apr 2026, 21:41:55 UTC
Prior SEC filing
29 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Matthew Booth, by power of attorney

Key filing fact

James M. Micali filed Form 4 for Urgent.ly Inc. (ULYX) on 28 Apr 2026.

Key facts

  • This page summarizes James M. Micali's Form 4 filing for Urgent.ly Inc. (ULYX).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 28 Apr 2026, 21:41.

Change

  • Previous filing in this sequence was filed on 29 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001253405 Primary reporting owner

MICALI JAMES M

Relationship
Director
Address
C/O URGENT.LY INC., 44927 GEORGE WASHINGTON BLVD., SUITE 265, ASHBURN
Signature
/s/ Matthew Booth, by power of attorney
Signature date
28 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ULYX transaction

Common Stock

Disposition pursuant to a tender of shares in a change of control transaction

Transaction value
Shares
-7,229
Change %
-85%
Price
Shares after
1,226
Date
25 Apr 2026
Ownership
Direct
Footnotes
F1, F2, F3, F4, F5
ULYX transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-1,226
Change %
-100%
Price
Shares after
0
Date
28 Apr 2026
Ownership
Direct
Footnotes
F4, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

James M. Micali is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 6 footnotes

Footnote F1

Excludes 396 shares of Issuer common stock that were inadvertently included in prior reports due to an administrative error.

Footnote F2

This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger entered into by and among the Issuer, Agero, Inc. ("Parent") and Medford Hawk, Inc., a wholly-owned subsidiary of Parent ("Purchaser"), dated as of March 13, 2026 (the "Merger Agreement"), pursuant to which the Purchaser completed a tender offer for the shares of Issuer common stock and thereafter merged with and into the Issuer effective as of April 28, 2026 (the "Effective Time").

Footnote F3

Pursuant to the Merger Agreement, each share of Issuer common stock was tendered in exchange for $5.50 in cash, without interest and subject to any applicable withholding taxes (the "Offer Price").

Footnote F4

The shares are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock.

Footnote F5

Includes 393 shares of Issuer common stock that were inadvertently excluded in prior reports due to an administrative error.

Footnote F6

Pursuant to the Merger Agreement and at the Effective Time, each RSU accelerated vesting in full and was cancelled in exchange for the right to receive an amount in cash, without interest and subject to withholding for all required taxes, equal to the product obtained by multiplying (i) the Offer Price by (ii) the total number of shares of Issuer common stock subject to the RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .